PARI Pharma announces the approval of its first innovative eFlow close...
The International Diabetes Federation (IDF) presented the interim resu...
To treat the vascular diseases Robocath, designs and develops innovati...
Leading healthcare science and technology company, Merck, announced th...
Alarmed at the increasing incidence of deaths and injuries in road cra...
Maker of novel robotic solutions, Medical Microinstruments S.r.l. (MMI...
Ebola virus disease, a severe and often fatal infection can be cured n...
Mylan and its partner Aspen announced the U.S. launch of Myleran (busu...
A global leader in bioanalytical testing, Eurofins Scientific, has suc...
The Comparison between Xultophy and IGlarLixi is done indirectly in pe...
Bayer and the Broad Institute of MIT and Harvard announced that they h...
Ricoh, headquartered in Tokyo, made an announcement that the RICOH MEG...
DuPont Nutrition & Health announces the development of a significa...
The U.S. Food and Drug Administration has approved the RxSight Inc. Li...
Merck and Pfizer Inc. announced that the Phase III JAVELIN Gastric 300...
According to the new research conducted by WHO, An estimated 1 in 10 m...
World Malaria Report 2017 by World Health Organisation says that after...
Italian biotech company, Dante Labs has developed the first DNA tests ...
